Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Opinion in Infectious Diseases

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QCO.0b013e32834cac17PMID 21986616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fatal Pneumocystis jirovecii pneumonia following immunosuppressive therapy with rituximab and prednisolone for posterior scleritis

  2012cited by this paper
• HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients.

  2012cited by this paper
• Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay

  2011cited by this paper
• Serum (1→3)-β-d-Glucan Levels in Primary Infection and Pulmonary Colonization with Pneumocystis jirovecii

  2011cited by this paper
• Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

  2011cited by this paper
• aN OutBreaK Of Pneumocystis jirovecii PNeumONIa wIth ONe PredOmINaNt GeNOtyPe IN reNaL traNsPLaNt reCIPIeNts: INterhumaN traNsmIssION Or a COmmON eNVIrONmeNtaL sOurCe?

  2011cited by this paper
• Update on the diagnosis and treatment of Pneumocystis pneumonia

  2011cited by this paper
• β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study.

  2011cited by this paper
• Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia.

  2011cited by this paper
• Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series

  2011cited by this paper
• Serum (1 → 3)-β-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value.

  2011cited by this paper
• Infectious complications in polymyositis and dermatomyositis: a series of 279 patients.

  2011cited by this paper
• Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.

  2011cited by this paper
• Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.

  2011cited by this paper
• Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients.

  2011cited by this paper
• Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.

  2011cited by this paper
• Serious infections in patients with inflammatory bowel disease receiving anti‐tumor‐necrosis‐factor‐alpha therapy: An Australian and New Zealand experience

  2010cited by this paper
• Cytokine profiles of bronchoalveolar lavage fluid in patients with pneumocystis pneumonia

  2010cited by this paper
• Two cases of fatal Pneumocystis jirovecii pneumonia as a complication of tacrolimus therapy in ulcerative colitis--a need for prophylaxis.

  2010cited by this paper
• A Cluster of Pneumocystis jirovecii Infection Among Outpatients with Rheumatoid Arthritis

  2010cited by this paper
• Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis

  2010cited by this paper
• Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study

  2010cited by this paper
• Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia.

  2010cited by this paper
• High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

  2010cited by this paper
• Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients

  2010cited by this paper
• The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients

  2010cited by this paper
• Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection

  2010cited by this paper
• Stealth and opportunism: alternative lifestyles of species in the fungal genus Pneumocystis.

  2010cited by this paper
• Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection.

  2010cited by this paper
• High Prevalence of Dihydropteroate Synthase Mutations in Pneumocystis jirovecii Isolated from Patients with Pneumocystis Pneumonia in South Africa

  2010cited by this paper
• Pneumocystis jiroveci pneumonia detected by FDG-PET

  2010cited by this paper
• Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.

  2010cited by this paper
• Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study.

  2010cited by this paper
• Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens.

  2009cited by this paper
• Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus

  2009cited by this paper
• Serum (1-3)-β-d-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy

  2009cited by this paper
• Detection of Pneumocystis jirovecii by Two Staining Methods and Two Quantitative PCR Assays

  2009cited by this paper
• Pneumocystis jiroveci (carinii) pneumonia following a second infusion of infliximab in a patient with ulcerative colitis.

  2009cited by this paper
• Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFalpha naive patient with ulcerative colitis.

  2009cited by this paper
• Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection

  2009cited by this paper
• Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.

  2009cited by this paper
• Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment

  2009cited by this paper
• Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center.

  2009cited by this paper
• Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates.

  2009cited by this paper
• Clinical Evaluation of a (1,3)-β-d-Glucan Assay for Presumptive Diagnosis of Pneumocystis jiroveci Pneumonia in Immunocompromised Patients

  2009cited by this paper
• Analysis of USRDS: Incidence and Risk Factors for Pneumocystis jiroveci Pneumonia

  2009cited by this paper
• Real‐time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection

  2009cited by this paper
• Outbreak of Pneumocystis jiroveci Pneumonia in Renal Transplant Recipients: P. jiroveci Is Contagious to the Susceptible Host

  2009cited by this paper
• IFN-gamma deficiency worsen Pneumocystis pneumonia with Th17 development in nude mice.

  2009cited by this paper
• Vertical Transmission of Pneumocystis jirovecii in Humans

  2009cited by this paper
• Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

  2009cited by this paper
• Pneumocystis species, co-evolution and pathogenic power.

  2008cited by this paper
• Pneumocystis jiroveci pneumonia in a patient with Wegener’s granulomatosis treated efficiently with caspofungin

  2008cited by this paper
• Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity.

  2008cited by this paper
• Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia.

  2008cited by this paper
• Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.

  2008cited by this paper
• Developments in the epidemiolgy of invasive fungal infections – implications for the empiric and targeted antifungal therapy

  2008cited by this paper
• Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas

  2008cited by this paper
• Molecular Evidence of Nosocomial Pneumocystis jirovecii Transmission among 16 Patients after Kidney Transplantation

  2008cited by this paper
• Evaluation of a real-time PCR assay for the diagnosis of Pneumocystis pneumonia.

  2008cited by this paper
• Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia.

  2008cited by this paper
• Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results.

  2008cited by this paper
• Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease

  2007cited by this paper
• Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients

  2007cited by this paper
• Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases

  2007cited by this paper
• Contribution of the (1→3)-β-d-Glucan Assay for Diagnosis of Invasive Fungal Infections

  2007cited by this paper
• (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.

  2007cited by this paper
• Development and evaluation of a real‐time PCR assay for detection of Pneumocystis jiroveci

  2007cited by this paper
• Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab

  2007cited by this paper
• Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features

  2007cited by this paper
• Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis

  2007cited by this paper
• Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIV-infected patients.

  2007cited by this paper
• Serum indicators for the diagnosis of pneumocystis pneumonia.

  2007cited by this paper
• Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays.

  2007cited by this paper
• An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?

  2007cited by this paper
• Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients

  2006cited by this paper
• Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples.

  2006cited by this paper
• Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens.

  2006cited by this paper
• Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab *

  2006cited by this paper
• Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

  2005cited by this paper
• Pneumocystis carinii pneumonia on F-18 FDG PET.

  2005cited by this paper
• FDG-PET imaging in Pneumocystis carinii pneumonia.

  2005cited by this paper
• Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.

  2005cited by this paper
• Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome.

  2005cited by this paper
• Molecular Evidence of Pneumocystis Transmission in Pediatric Transplant Unit

  2005cited by this paper
• (1-->3)-beta-D glucan is a diagnostic and negative prognostic marker for Pneumocystis carinii pneumonia in patients with connective tissue disease.

  2005cited by this paper
• Progression of diverticular colitis to ulcerative colitis.

  2005cited by this paper
• Molecular diagnosis of Pneumocystis pneumonia.

  2005cited by this paper
• An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

  2005cited by this paper
• Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features.

  2005cited by this paper
• Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease.

  2004cited by this paper
• Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.

  2004cited by this paper
• Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia

  2004cited by this paper
• Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens.

  2004cited by this paper
• Molecular Evidence of Interhuman Transmission of Pneumocystis Pneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients

  2004cited by this paper
• A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients.

  2004cited by this paper
• Pneumocystis carinii Pneumonia During Maintenance Anti–Tumor Necrosis Factor-&agr; Therapy with Infliximab for Crohn’s Disease

  2004cited by this paper
• Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

  2004cited by this paper
• PCR diagnosis of Pneumocystis carinii on sputum and bronchoalveolar lavage samples in immuno-compromised patients

  2004cited by this paper
• Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer

  2003cited by this paper

• Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG

  2025cites this paper
• Evolving Risk Factors and Predisposing Conditions of Pneumocystis Pneumonia in Non-HIV Patients: A Seven-Year Multicenter Study.

  2025cites this paper
• Caspofungin Combined With TMP/SMZ in Treatment of Intractable Acute Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients: Case Report and Literature Review

  2025cites this paper
• Clinical decision making impact of Next-Generation Sequencing in Pneumocystis jirovecii infection: infection characteristics and prognosis.

  2025cites this paper
• CRISPR-Mediated Detection of Pneumocystis Transcripts in Bronchoalveolar, Oropharyngeal, and Serum Specimens for Pneumocystis Pneumonia Diagnosis.

  2025cites this paper
• Standardization and Clinical Evaluation of a Real-Time PCR Assay for the Diagnosis of Pneumocystis jirovecii Pneumonia

  2025cites this paper
• Significance of positive semi-quantitative PCR tests on bronchoalveolar lavage for Pneumocystis jirovecii pneumonia in HIV-negative immunocompromised ICU patients with acute respiratory failure

  2025cites this paper
• A Rare Presentation of Synchronous Pneumocystis Pneumonia and Cutaneous Nocardiosis on 18F-FDG PET/CT

  2025cites this paper
• CRISPR-mediated detection of Pneumocystis transcripts in bronchoalveolar, oropharyngeal, and serum specimens for Pneumocystis pneumonia diagnosis

  2025cites this paper
• Positivity of polymerase chain reaction and Grocott staining in relation to the duration from therapy initiation to examination in Pneumocystis jirovecii pneumonia.

  2025cites this paper
• Prevalence of Pneumocystis jirovecii in Smear Negative Sputum Samples at the Coast General Teaching and Refferral Hospital in Kenya

  2024cites this paper
• Prognostic Factors for Mortality in Patients With Autoimmune Diseases Complicated by Pneumocystis Pneumonia

  2024cites this paper
• Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients

  2024cites this paper
• Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection - Derivation of a clinical risk score.

  2024cites this paper
• Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR

  2023cites this paper
• Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts’ Opinion and Systematic Review from the Literature

  2023cites this paper
• Machine Learning Models for Prediction of Severe Pneumocystis carinii Pneumonia after Kidney Transplantation: A Single-Center Retrospective Study

  2023cites this paper
• Pneumocystis pneumonia diagnosed by repeated measurements of β-D-glucan levels

  2023cites this paper
• Pulmonary Pneumocystis in HIV-Negative Patients: About 13 Cases

  2023cites this paper
• Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation.

  2023cites this paper
• A machine learning diagnostic model for Pneumocystis jirovecii pneumonia in patients with severe pneumonia

  2023cites this paper
• Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection

  2023cites this paper
• Pneumocystis Jirovecii Pneumonia (PCP) in HIV Patient: A Case Report

  2023cites this paper
• Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning–based approach

  2023cites this paper
• Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients

  2022cites this paper
• Risk of Pneumocystis jirovecii Pneumonia among Solid Organ Transplant Recipients: A Population-Based Study

  2022cites this paper
• Metagenomic next-generation sequencing in diagnosing Pneumocystis jirovecii pneumonia: A case report

  2022cites this paper
• Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report

  2022cites this paper
• Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia.

  2022cites this paper
• Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin

  2022cites this paper
• Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.

  2022cites this paper
• Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing

  2022cites this paper
• Pneumocystis Jirovecii Pneumonia Diagnosis via Metagenomic Next-Generation Sequencing

  2022cites this paper
• A Rare Case of Ulcerative Colitis with Severe Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review

  2021cites this paper
• Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor

  2021cites this paper
• The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature

  2021cites this paper
• Risk Factors of Mortality From Pneumocystis Pneumonia in Non-HIV Patients: A Meta-Analysis

  2021cites this paper
• Diagnosis of Pneumocystis jirovecii Pneumonia by Real Time PCR: An Analysis of 10 Clinical Cases

  2021cites this paper
• Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: A systematic review and meta-analysis.

  2021cites this paper
• Diagnostic accuracy of serum (1-3)-β-D-Glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.

  2020cites this paper
• Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples

  2020cites this paper
• Pneumocystis Infection in Two Patients Treated with Both Immune Checkpoint Inhibitor and Corticoids

  2020cites this paper
• Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes

  2020cites this paper
• Recent Advances in the Diagnosis and Management of Pneumocystis Pneumonia

  2020cites this paper
• Comparison of real-time PCR, indirect immunofluorescence antibody assay, and different staining techniques for the diagnosis of Pneumocystis jirovecii

  2020cites this paper
• Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections

  2020cites this paper
• Evaluation of a commercial Loop‐mediated Isothermal Amplification (LAMP) assay for rapid detection of Pneumocystis jirovecii

  2020cites this paper
• Lower Mortality Associated With Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients With Pneumocystis jirovecii Pneumonia: A Single-Institution Retrospective US Cohort Study

  2020cites this paper
• Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*

  2020cites this paper
• Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice

  2020cites this paper
• Crossing a New Threshold: Use of Elevated (1,3)-Beta-D-Glucan Levels to Distinguish Causation from Colonization in Pneumocystis jirovecii PCR Positive Cancer Patients.

  2019cites this paper
• Next generation sequencing in early diagnosis of pneumocystis jirovecii pneumonia after chemotherapy: a case report

  2019cites this paper
• Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis

  2019cites this paper
• m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis

  2019cites this paper
• Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients

  2019cites this paper
• Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia

  2019cites this paper
• Acute Pulmonary Infiltrates in Patients with Rheumatoid Arthritis: Differential Diagnosis and Management

  2018cites this paper
• Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention

  2018cites this paper
• A Molecular Window into the Biology and Epidemiology of Pneumocystis spp

  2018cites this paper
• Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid

  2018cites this paper
• Lung Disease Associated with Rheumatoid Arthritis

  2018cites this paper
• Bacterial and Fungal Infections in Rheumatoid Arthritis

  2018cites this paper
• Pneumocystis Jirovecii Pneumonia During Sirolimus Therapy for Kaposiform Hemangioendothelioma

  2018cites this paper
• Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia

  2018cites this paper
• Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii.

  2017cites this paper
• Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression

  2017cites this paper
• Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review

  2017cites this paper
• Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice

  2016cites this paper
• NASPGHAN Clinical Report: Surveillance, Diagnosis, and Prevention of Infectious Diseases in Pediatric Patients With Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Inhibitors.

  2016cites this paper
• High Diagnostic Value of a New Real-Time Pneumocystis PCR from Bronchoalveolar Lavage in a Real-Life Clinical Setting

  2016cites this paper
• Copy Number Variation of Mitochondrial DNA Genes in Pneumocystis jirovecii According to the Fungal Load in BAL Specimens

  2016cites this paper
• Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease

  2016cites this paper
• Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib.

  2016cites this paper
• Pneumonia After Hematopoietic Stem Cell Transplantation

  2016cites this paper
• ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

  2016cites this paper
• Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing

  2016cites this paper
• Functional Characterization of Pneumocystis carinii Inositol Transporter 1

  2016cites this paper
• THE EFFECTS OF ANTI-CD20 THERAPY ON SUSCEPTIBILITY TO PNEUMOCYSTIS INFECTION AND THE CD4+ T-CELL SIGNALS THAT MEDIATE CLEARANCE

  2015cites this paper
• Pneumocystis Pneumonia in Inflammatory Bowel Disease: The Costs of Immunosuppression

  2015cites this paper
• Pneumocystis Pneumonia in Solid-Organ Transplant Recipients

  2015cites this paper
• Pathological and protective immunity to Pneumocystis infection

  2015cites this paper
• Pneumocystis jiroveci pneumonia with recurrent pneumothorax requiring pleurodesis in inflammatory bowel disease

  2015cites this paper
• New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards

  2015cites this paper
• Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii

  2015cites this paper
• Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis

  2015cites this paper
• Pneumocystis jirovecci pneumonia in connective tissue diseases: Comparison with other immunocompromised patients.

  2015cites this paper
• Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses.

  2015cites this paper
• Updates on Aspergillus, Pneumocystis and Other Opportunistic Pulmonary Mycoses

  2015cites this paper
• Pathogenesis of Pneumocystis jirovecii Pneumonia

  2015cites this paper
• [Pneumocystis pneumonia in HIV-negative adults].

  2015cites this paper
• Actualización sobre Aspergillus, Pneumocystis y otras micosis pulmonares oportunistas

  2015cites this paper
• Actualización sobre Aspergillus, Pneumocystis y otras micosis pulmonares oportunistas

  2015cites this paper
• Infections after orthotopic liver transplantation.

  2014cites this paper
• Pneumocystis carinii pneumonia at thirty-eight months after kidney transplantation

  2014cites this paper
• Acute and chronic lung infections. Novel pathogens, diagnostics, and therapeutics.

  2014cites this paper
• Three cases of presumed pneumocystis pneumonia in patients receiving bortezomib therapy for multiple myeloma

  2014cites this paper
• Outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients.

  2014cites this paper
• Pneumocystis Pneumonia in Patients Treated With Long-Term Steroid Therapy for Symptom Palliation

  2014cites this paper
• Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients.

  2014cites this paper
• Nonmolecular methods for the diagnosis of respiratory fungal infections.

  2014cites this paper